Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

GastroEsophageal Cancer × Exercise × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 214 Breast Neoplasms 119 Neoplasms 93 Prostatic Neoplasms 33 Fatigue 29 Obesity 23 Colorectal Neoplasms 21 Lung Neoplasms 17 Colonic Neoplasms 15 Polycystic Ovary Syndrome 14 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphedema 11 Lymphoma 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Hematologic Neoplasms 9 Weight Loss 8 Multiple Myeloma 8 Leukemia 8 Cardiotoxicity 8 Brain Neoplasms 8 Pancreatic Neoplasms 7 Insulin Resistance 7 Carcinoma, Non-Small-Cell Lung 7 Overweight 6 Cognitive Dysfunction 6 Sarcopenia 5 Peripheral Nervous System Diseases 5 Lymphoma, Follicular 5

Interventions

Surveys and Questionnaires 2 Lapatinib 1 Immune Checkpoint Inhibitors 1 Exercise 1 Diet Therapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03490565 2023-06-22

PRESET-RCT

Rigshospitalet, Denmark

Phase NA Active not recruiting

Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡